[Federal Register Volume 87, Number 197 (Thursday, October 13, 2022)]
[Notices]
[Pages 62105-62106]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-22215]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2022-0120]


Advisory Committee to the Director (ACD), Centers for Disease 
Control and Prevention (CDC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting and request for comment.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting of the Advisory Committee to the 
Director, Centers for Disease Control and Prevention (ACD, CDC). This 
is a hybrid meeting, accessible both in person and virtually (webcast 
live via the World Wide Web). It is open to the public and limited only 
by the space available. Time will be available for public comment.

DATES: The meeting will be held on November 2, 2022, from 10:00 a.m. to 
4:30 p.m. and November 3, 2022 from 9:00 a.m. to 12:00 p.m., EDT (times 
are subject to change).
    Written comments must be received on or before October 24, 2022.

ADDRESSES: Meeting address: CDC Roybal Campus, Building 19, Room 3B, 
1600 Clifton Road NE, Atlanta, Georgia 30329-4027. The conference room 
accommodates approximately 200 people.
    Please note that the meeting location, the CDC Roybal Campus, is a 
federal facility and in-person access is limited to United States 
citizens unless prior authorizations, taking up to 30 to 60 days, have 
been made. Visitors must follow all directions for access to CDC 
facilities. Directions for visitors to CDC, including safety 
requirements related to COVID-19, are available at https://www.cdc.gov/screening/visitors.html.
    Registration: You must register to attend this meeting in person. 
If you wish to attend in person, please submit a request by email to 
[email protected] or by telephone at (404) 639-0390 at least 5 
business days in advance of the meeting. No registration is required to 
view the meeting via the World Wide Web. Information for accessing the 
webcast will be available at https://www.cdc.gov/about/advisory-committee-director/.
    Written comments: You may submit comments, identified by Docket No. 
CDC-2022-0120, by either of the methods listed below. Do not submit 
comments for the docket by email. CDC does not accept comments for the 
docket by email.
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: Kerry Caudwell, MPA, Centers for Disease Control and 
Prevention, 1600 Clifton Road NE, Mailstop H21-10, Atlanta, Georgia 
30329-4027. Attn: Docket No. CDC-2022-0120.
    Instructions: All submissions received must include the agency name 
and Docket Number. All relevant comments received will be posted 
without change to https://www.regulations.gov, including any personal 
information provided. For access to the docket to read background 
documents or comments received, go to https://www.regulations.gov. 
Written comments received in advance of the meeting will be included in 
the official record of the meeting.

FOR FURTHER INFORMATION CONTACT: Kerry Caudwell, MPA, Office of the 
Chief of Staff, Centers for Disease Control and Prevention, 1600 
Clifton Road NE, Mailstop H21-10, Atlanta, Georgia 30329-4027; 
Telephone: (404) 639-0390; Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Advisory Committee to the Director, CDC, shall advise 
the Secretary, HHS, and the Director, CDC, on policy and broad 
strategies that will enable CDC to fulfill its mission of protecting 
health through health promotion, prevention, and preparedness. The 
committee recommends ways to prioritize CDC's activities, improve 
results, and address health disparities. It also provides guidance to 
help CDC work more effectively with its various private and public 
sector constituents to make health protection a practical reality.
    Matters to be Considered: The agenda will include discussions 
regarding CDC's current and future work in the following topic areas: 
(1) data modernization; (2) laboratory quality; and (3) health equity. 
The ACD will hear reports from its working groups on these three 
topics. In addition, the ACD will have presentations on the COVID-19 
and Monkeypox responses, Social Determinants of Health and CDC's Moving 
Forward initiative. Agenda items are subject to change as priorities 
dictate.

Public Participation

    Interested persons or organizations are invited to participate by 
submitting written views, recommendations, and

[[Page 62106]]

data. Please note that comments received, including attachments and 
other supporting materials, are part of the public record and are 
subject to public disclosure. Comments will be posted on https://www.regulations.gov. Therefore, do not include any information in your 
comment or supporting materials that you consider confidential or 
inappropriate for public disclosure. If you include your name, contact 
information, or other information that identifies you in the body of 
your comments, that information will be on public display. CDC will 
review all submissions and may choose to redact, or withhold, 
submissions containing private or proprietary information such as 
Social Security numbers, medical information, inappropriate language, 
or duplicate/near duplicate examples of a mass-mail campaign. CDC will 
carefully consider all comments submitted into the docket.
    Oral Public Comment: This meeting will include time for members of 
the public to make an oral comment. Oral public comment will occur 
before any scheduled votes. Priority will be given to individuals who 
submit a request to make an oral public comment before the meeting 
according to the procedure below.
    Procedure for Oral Public Comment: All persons interested in making 
an oral public comment at the November 2 and 3, 2022, ACD meeting must 
submit a request by visiting https://www.cdc.gov/about/advisory-committee-director/ no later than 11:59 p.m., EDT, October 24, 2022, 
according to the instructions provided.
    If the number of persons requesting to speak is greater than can be 
reasonably accommodated during the scheduled time, CDC will conduct a 
lottery to determine the speakers for the scheduled public comment 
session. CDC staff will notify individuals regarding their request to 
speak via email by October 26, 2022. To accommodate the significant 
interest in participation in the oral public comment session of ACD 
meetings, each speaker will be limited to 2 minutes, and each speaker 
may only speak once per meeting.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-22215 Filed 10-12-22; 8:45 am]
BILLING CODE 4163-18-P